Insider Trading activities of Onconova Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Onconova Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Onconova Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Onconova Therapeutics, Inc. since 2005. The reporting company's ticker symbol is ONTX. The reporting company's CIK number is 1130598.
The total value of stock buying since 2005 is $51,397,599.
The total value of stock sales since 2005 is $1,453,774.
The total value of stock option exercises since 2005 is $717,738.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Onconova Therapeutics, Inc. (ONTX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-08 0 $0 99,999 $45,159 0 $0
2018-05 10,000 $3,800 0 $0 0 $0
2018-04 24,585,408 $9,343,748 0 $0 0 $0
2018-02 1,350,000 $1,318,200 0 $0 0 $0
2017-04 160,003 $336,004 0 $0 0 $0
2016-06 0 $0 0 $0 170 $1,079
2014-07 0 $0 0 $0 18,754 $50,073
2014-05 0 $0 0 $0 27,084 $36,021
2014-02 286,960 $2,430,550 40,000 $603,600 53,543 $321,258
2014-01 114,590 $1,365,376 40,000 $601,600 40,000 $206,700
2013-12 0 $0 0 $0 32,036 $42,607
2013-11 66,900 $827,191 0 $0 0 $0
2013-10 0 $0 0 $0 5,000 $30,000
2013-07 2,384,334 $35,772,730 0 $0 5,000 $30,000
2013-02 0 $0 13,543 $203,415 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Onconova Therapeutics, Inc. insiders (ONTX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-08-29 Hoffman Michael B (Director) Sale 29,999 .45 13,529
2018-08-28 Hoffman Michael B (Director) Sale 50,000 .45 22,550
2018-08-27 Hoffman Michael B (Director) Sale 20,000 .45 9,080
2018-05-29 Bienen Henry S Buy 10,000 .38 3,800
2018-04-27 Reddy E Premkumar Buy 282,350 .00 0
2018-04-27 683 Capital Management, Llc Buy 11,838,235 .42 5,031,249
2018-04-27 Hoffman Michael B Buy 2,211,765 .00 0
2018-04-27 Tyndall Capital Partners L P Buy 10,147,058 .42 4,312,499
2018-04-27 Stover Jack E Buy 47,100 .00 0
2018-04-27 Marino James J Buy 58,900 .00 0
2018-02-08 683 Capital Partners, Lp Buy 200,000 1.04 207,200
2018-02-08 Tyndall Capital Partners L P Buy 1,100,000 1.01 1,111,000
2018-02-08 Marino James J Buy 50,000 .00 0
2017-04-26 Guerin Mark Patrick (Chief Financial Officer) Buy 1,429 2.10 3,000
2017-04-26 Kumar Ramesh (President and CEO) Buy 23,810 2.10 50,001
2017-04-26 Reddy E Premkumar Buy 119,048 2.10 250,000
2017-04-26 Bienen Henry S Buy 3,810 2.10 8,001
2017-04-26 Marino James J Buy 11,906 2.10 25,002
2016-06-30 Maniar Manoj (SVP - Product Development) Option Ex 50 6.50 325
2016-06-29 Groopman Jerome Option Ex 10 5.20 52
2016-06-27 Marino James J Option Ex 10 5.20 52
2016-06-24 Fruchtman Steven M (Chief Medical Officer) Option Ex 100 6.50 650
2014-07-07 Hoffman Michael B Option Ex 18,754 2.67 50,073
2014-05-02 Reddy E Premkumar Option Ex 27,084 1.33 36,021
2014-02-21 Michael & Jane Hoffman 2013 Descendants Buy 71,740 8.91 639,203
2014-02-21 Hoffman Michael B Buy 71,740 8.91 639,203
2014-02-20 Michael & Jane Hoffman 2013 Descendants Buy 71,740 8.03 576,072
2014-02-20 Hoffman Michael B Buy 71,740 8.03 576,072
2014-02-10 Kumar Ramesh (President and CEO) Sale 20,000 15.11 302,200
2014-02-10 Kumar Ramesh (President and CEO) Option Ex 20,000 6.00 120,000
2014-02-07 Kumar Ramesh (President and CEO) Option Ex 13,543 6.00 81,258
2014-02-03 Kumar Ramesh (President and CEO) Sale 20,000 15.07 301,400
2014-02-03 Kumar Ramesh (President and CEO) Option Ex 20,000 6.00 120,000
2014-01-31 Kumar Ramesh (President and CEO) Sale 20,000 15.03 300,600
2014-01-31 Kumar Ramesh (President and CEO) Option Ex 20,000 6.00 120,000
2014-01-30 Kumar Ramesh (President and CEO) Sale 20,000 15.05 301,000
2014-01-30 Kumar Ramesh (President and CEO) Option Ex 20,000 4.33 86,700
2014-01-27 Michael & Jane Hoffman 2013 Descendants Buy 25,589 11.86 303,485
2014-01-27 Hoffman Michael B Buy 25,589 11.86 303,485
2014-01-24 Michael & Jane Hoffman 2013 Descendants Buy 31,706 11.96 379,203
2014-01-24 Hoffman Michael B Buy 31,706 11.96 379,203
2013-12-19 Reddy E Premkumar Option Ex 32,036 1.33 42,607
2013-11-22 Michael & Jane Hoffman 2013 Descendants Buy 5,000 14.38 71,900
2013-11-22 Hoffman Michael B Buy 5,000 14.38 71,900
2013-11-18 Michael & Jane Hoffman 2013 Descendants Buy 5,000 11.87 59,349
2013-11-18 Reddy E Premkumar Buy 5,000 12.10 60,500
2013-11-18 Hoffman Michael B Buy 5,000 11.87 59,349
2013-11-15 Michael & Jane Hoffman 2013 Descendants Buy 19,700 12.03 236,991
2013-11-15 Kumar Ramesh (President and CEO) Buy 1,100 12.02 13,222
2013-11-15 Bienen Henry S Buy 1,400 12.13 16,989
2013-11-15 Hoffman Michael B Buy 19,700 12.03 236,991
2013-10-10 Altland James (SVP, Finance & Corp. Develop.) Option Ex 5,000 6.00 30,000
2013-07-30 Michael & Jane Hoffman 2013 Descendants Buy 1,000,000 15.00 15,000,000
2013-07-30 Altland James (SVP, Finance & Corp. Develop.) Option Ex 5,000 6.00 30,000
2013-07-30 Kumar Ramesh (President and CEO) Buy 6,667 15.00 100,005
2013-07-30 Reddy E Premkumar Buy 20,000 15.00 300,000
2013-07-30 Bienen Henry S Buy 6,667 15.00 100,005
2013-07-30 Hoffman Michael B Buy 1,000,000 15.00 15,000,000
2013-07-30 Mehta Viren Buy 16,667 15.00 250,005
2013-07-30 Mckearn Thomas J (President, R&D) Buy 3,333 15.00 49,995
2013-07-30 Baxter International Inc Buy 330,000 15.00 4,950,000
2013-07-25 Reddy E Premkumar Buy 1,000 22.72 22,720
2013-02-07 Kumar Ramesh (President and CEO) Sale 13,543 15.02 203,415

Insider trading activities including stock purchases, stock sales, and option exercises of ONTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Onconova Therapeutics, Inc. (symbol ONTX, CIK number 1130598) see the Securities and Exchange Commission (SEC) website.